Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesPayablesPreferred Stock LiabilitiesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Translational Development Acquisition (TDAC) Assets (2023 - 2026)

Translational Development Acquisition's Assets history spans 4 years, with the latest figure at $183.3 million for Q1 2026.

  • On a quarterly basis, Assets rose 3.82% to $183.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $183.3 million, a 3.82% increase, with the full-year FY2025 number at $181.7 million, up 3.83% from a year prior.
  • Assets came in at $183.3 million for Q1 2026, up from $181.7 million in the prior quarter.
  • The five-year high for Assets was $183.3 million in Q1 2026, with the low at $2021.0 in Q4 2023.
  • Historically, Assets has averaged $153.5 million across 4 years, with a median of $178.2 million in 2025.
  • Biggest five-year swings in Assets: surged 8659008.31% in 2024 and later rose 3.82% in 2026.
  • Year by year, Assets stood at $2021.0 in 2023, then skyrocketed by 8659008.31% to $175.0 million in 2024, then grew by 3.83% to $181.7 million in 2025, then grew by 0.91% to $183.3 million in 2026.
  • Business Quant data shows Assets for TDAC at $183.3 million in Q1 2026, $181.7 million in Q4 2025, and $180.0 million in Q3 2025.